This Million Targets Drug: A $7M Bet on a CNS Breakthrough
A focused look at a $7 million wager on a CNS drug maker in Phase 3. Learn what this move signals about biotech momen...
Explore credit cards with the best cashback rates to maximize your savings on everyday purchases. Find out which cards offer the highest rewards.
6,155 articlesA focused look at a $7 million wager on a CNS drug maker in Phase 3. Learn what this move signals about biotech momen...
Oil markets face geopolitical headwinds and growing demand, keeping prices above the $90 threshold. This article iden...
Insider trades can hint at a company's future, but not every move is meaningful. This article shows how to filter sig...
Geopolitics can push oil to $100 a barrel, but certain pipeline stocks thrive on throughput rather than price. Learn ...
Insider trading activity can reveal how executives view their company’s future. This article digs into a real-world c...
A newly launched XRP ETF promises to deliver twice the daily moves of XRP, inviting traders to pursue a quick double ...
Pre-marketing for homes, dubbed coming soon listings, has moved from niche tests to a nationwide driver of housing de...
A multibillion-dollar air defense push in Greece is drawing investor attention to Lockheed Martin and other defense c...
A top market strategist calls for exiting the Magnificent 7 amid lofty valuations and fading earnings promises, hinti...
Thousands of shelved drug candidates could unlock therapies for rare diseases, but funding and partnerships lag. The ...
NovaBridge Crypto cuts 12% of its workforce to accelerate its AI strategy, signaling a wider shift toward AI-driven e...
If I had just $500 to invest in the AI wave, I’d narrow it to one strong option. This guide explains why and how to m...